Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on: February 24,2024

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on:February 24,2024

Bio-inspired neuroprosthetics: Sending signals the brain can understand

by Ori Schipper,ETH ZurichNeuroscience-driven development of a biomimetic neuroprosthetic device. The successful development of a somatosensory neuroprosthesis is based on three main pillars: (1

Updated on: April 09,2024

Bio-inspired neuroprosthetics: Sending signals the brain can understand

by Ori Schipper,ETH ZurichNeuroscience-driven development of a biomimetic neuroprosthetic device. The successful development of a somatosensory neuroprosthesis is based on three main pillars: (1

Updated on:April 09,2024

New insight into role of amyloid beta in Alzheimer's disease

by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul

Updated on: April 02,2024

New insight into role of amyloid beta in Alzheimer's disease

by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul

Updated on:April 02,2024

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped

Updated on: April 01,2024

MS treatment that 'resets' immune system may halt disease progression for at least five years

by Imperial College LondonDemyelination by MS. The CD68 colored tissue shows several macrophages in the area of the lesion. Original scale 1:100. Credit:CC BY-SA 3.0Marvin 101/Wikiped

Updated on:April 01,2024

Obesity linked to neurodegeneration through insulin resistance

byPublic Library of ScienceSugarfly. Artistic rendering generated by DALL.E the prompt used is "The drawing of the fruit fly Drosophila in a dark background in the style of Seurat." Th

Updated on: January 10,2024

Obesity linked to neurodegeneration through insulin resistance

byPublic Library of ScienceSugarfly. Artistic rendering generated by DALL.E the prompt used is "The drawing of the fruit fly Drosophila in a dark background in the style of Seurat." Th

Updated on:January 10,2024

Improving blood vessel health in the brain may help combat Alzheimer's

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainIn patients with Alzheimer's disease, amyloid-beta protein fragments accumulate i

Updated on: June 04,2024

Improving blood vessel health in the brain may help combat Alzheimer's

by Massachusetts General HospitalPET scan of a human brain with Alzheimer's disease. Credit: public domainIn patients with Alzheimer's disease, amyloid-beta protein fragments accumulate i

Updated on:June 04,2024

Research team discovers new role of cerebellum in coordinating the brain network essential for social recognition memory

by Alex Smith,University of Minnesota Medical SchoolAltered c-Fos expression by chemogenetic excitation of MLIs in cerebellar lobules IV-VII following the social recognition test.aDe

Updated on: January 10,2024

Research team discovers new role of cerebellum in coordinating the brain network essential for social recognition memory

by Alex Smith,University of Minnesota Medical SchoolAltered c-Fos expression by chemogenetic excitation of MLIs in cerebellar lobules IV-VII following the social recognition test.aDe

Updated on:January 10,2024

Study reveals shared blueprint in brain development across different functional areas

by University of Minnesota Medical SchoolSpontaneous activity is highly modular in early development across diverse cortical areas. (A) Experimental schematic. Spontaneous activity was imaged at

Updated on: March 19,2024

Study reveals shared blueprint in brain development across different functional areas

by University of Minnesota Medical SchoolSpontaneous activity is highly modular in early development across diverse cortical areas. (A) Experimental schematic. Spontaneous activity was imaged at

Updated on:March 19,2024

Multi-omics analysis identifies molecularly defined Alzheimer's disease subtypes

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large

Updated on: June 15,2024

Multi-omics analysis identifies molecularly defined Alzheimer's disease subtypes

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large

Updated on:June 15,2024

COVID-19 infection linked to higher risk of neuropathy

byWashington University School of MedicineTesting centers abounded in the early days of the pandemic. Now researchers at Washington University School of Medicine have found that many people who

Updated on: March 30,2024

COVID-19 infection linked to higher risk of neuropathy

byWashington University School of MedicineTesting centers abounded in the early days of the pandemic. Now researchers at Washington University School of Medicine have found that many people who

Updated on:March 30,2024

Could loss of smell from COVID-19 create future 'dementia wave?'

byAmerican Physiological SocietyCredit: Unsplash/CC0 Public DomainA review of studies about the effect of SARS-CoV-2—the virus that causes COVID-19—on the olfactory system introduces questions a

Updated on: January 21,2024

Could loss of smell from COVID-19 create future 'dementia wave?'

byAmerican Physiological SocietyCredit: Unsplash/CC0 Public DomainA review of studies about the effect of SARS-CoV-2—the virus that causes COVID-19—on the olfactory system introduces questions a

Updated on:January 21,2024

Photostimulation of lymphatic clearance of β-amyloid: A new strategy for Alzheimer's disease therapy

by Higher Education PressPhotostimulation-induced stimulation of lymphatic clearance of Aβ from the brain in 5xFAD mice. Credit: Dongyu Li, Hao Lin, Silin Sun, Shaojun Liu, Zhang Liu, Yuening He, Jing

Updated on: February 24,2024

Photostimulation of lymphatic clearance of β-amyloid: A new strategy for Alzheimer's disease therapy

by Higher Education PressPhotostimulation-induced stimulation of lymphatic clearance of Aβ from the brain in 5xFAD mice. Credit: Dongyu Li, Hao Lin, Silin Sun, Shaojun Liu, Zhang Liu, Yuening He, Jing

Updated on:February 24,2024